TiGenix files Registration Statement for proposed initial public offering in the United States

Sanifit announces the creation of a Steering Committee for its Phase 2b ESRD Clinical Program with SNF472

Sanifit and Mitelos make available to Doctors and patients a new alternative in osteoporosis

TiGenix completes enrolment of its Phase I/II study in acute myocardial infarction

CVRx® Announces Expedited Access Pathway Designation by FDA for Barostim Therapy® for the Treatment of Heart Failure in Order to Accelerate Access for US Patients

Minoryx Therapeutics completes Series A funding of €19.4M ($21.7M)

AM-Pharma publishes further preclinical data on recAP to treat Acute Kidney Injury

AM-Pharma and Pfizer Inc. shortlisted for “Best Partnership Alliance” in 2015 Scrip Awards

IRB Barcelona identifies the gene responsible for metastasis of breast cancer to the bone

TiGenix Business and Financial Update for the First Half of 2015